BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15527862)

  • 1. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.
    Hesse S; Barthel H; Schwarz J; Sabri O; Müller U
    Neurosci Biobehav Rev; 2004 Oct; 28(6):547-63. PubMed ID: 15527862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol.
    Zhuang Z; Choi S; Hou C; Mu M; Kung M; Acton PD; Kung HF
    Nucl Med Biol; 2000 Feb; 27(2):169-75. PubMed ID: 10773546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aging on serotonin transporter availability and its response to fluvoxamine in the living brain: PET study with [(11)C](+)McN5652 and [(11)C](-)McN5652 in conscious monkeys.
    Kakiuchi T; Tsukada H; Fukumoto D; Nishiyama S
    Synapse; 2001 Jun; 40(3):170-9. PubMed ID: 11304754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
    Frankle WG; Narendran R; Huang Y; Hwang DR; Lombardo I; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Jun; 57(12):1510-6. PubMed ID: 15953487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons.
    Montañez S; Daws LC; Gould GG; Frazer A
    J Neurochem; 2003 Nov; 87(4):861-7. PubMed ID: 14622117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
    Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging neurochemical endophenotypes: promises and pitfalls.
    Martinez D; Broft A; Laruelle M
    Pharmacogenomics; 2001 Aug; 2(3):223-37. PubMed ID: 11535111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.
    Jarkas N; McConathy J; Voll RJ; Goodman MM
    J Med Chem; 2005 Jun; 48(13):4254-65. PubMed ID: 15974579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporter and memory.
    Meneses A; Perez-Garcia G; Ponce-Lopez T; Tellez R; Castillo C
    Neuropharmacology; 2011 Sep; 61(3):355-63. PubMed ID: 21276807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter.
    Jagust WJ; Eberling JL; Biegon A; Taylor SE; VanBrocklin HF; Jordan S; Hanrahan SM; Roberts JA; Brennan KM; Mathis CA
    J Nucl Med; 1996 Jul; 37(7):1207-14. PubMed ID: 8965200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of PET in clinical trials of psychotropic drugs].
    Suhara T; Morimoto T
    Seishin Shinkeigaku Zasshi; 2005; 107(7):704-11. PubMed ID: 16250122
    [No Abstract]   [Full Text] [Related]  

  • 16. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
    J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Levels and molecular heterogeneity of serotonin transporter protein in platelets of patients with different mental diseases: a comparative analysis with the use of monoclonal and polyclonal antibodies].
    Brusov OS; Faktor MI; Zlobina GP; Bologov PV; Kaleda VG; Oleĭchik IV; Korenev AN; Piatnitskiĭ AN; Dupin AM; Katasonov AB; Morozova MA; Beniashvili AG; Lozier RKh; Pavlova EV; Segal OL; Massino IuS; Dmitriev AD
    Vestn Ross Akad Med Nauk; 2001; (7):37-42. PubMed ID: 11523428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional serotonin transporter availability and depression are correlated in Wilson's disease.
    Hesse S; Barthel H; Hermann W; Murai T; Kluge R; Wagner A; Sabri O; Eggers B
    J Neural Transm (Vienna); 2003 Aug; 110(8):923-33. PubMed ID: 12898347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporter: a potential substrate in the biology of suicide.
    Purselle DC; Nemeroff CB
    Neuropsychopharmacology; 2003 Apr; 28(4):613-9. PubMed ID: 12655305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.